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Araki et al., http://www.jcb.org/cgi/content/full/jcb.201303027/DC1 Figure S1 . Ero1- binds to ER-resident oxidoreductases. (A) Ero1-(WT)-FLAG was expressed in HEK293T cells, and anti-FLAG immunoprecipitates were analyzed by direct nanoflow liquid chromatography/tandem mass spectrometry. Preys identified during eight independent trials are listed. Each number indicates the identified peptide number of each protein in individual experiments. Gray bars show the poor reproducible preys or nonoxidoreductases. (B) HEK293T cells were transfected with a series of oxidoreductases, including the wild type (WT) and their mutants (CA and AA), as indicated. Cell lysates were immunoprecipitated by anti-FLAG antibody, subjected to SDS-PAGE on two separate membranes, and analyzed by immunoblotting with anti-Ero1- (top) and anti-FLAG (bottom) antibodies. A black line on the right indicates the removal of intervening lanes from one of the membranes for presentation purposes. Note that ERp44 contains a CRFS motif in its active site, and its mutant is ARFS (AS). (C) Recombinant Ero1-(WT) proteins were immobilized on the surface of a sensor chip. Binding responses were collected at five different concentrations (0.444-36 µM, in a threefold dilution series) of oxidoreductases under redox conditions equivalent to those in the ER (GSH/GSSG ratio = 4:1). Association or dissociation rate constants (k on or k off ) were determined using a two-state reaction model. (D) SPR-quantified result. Data represent means ± SE from at least three individual experiments. (E) Assays were conducted in a sealed chamber starting with air-saturated buffer containing 10 mM GSH, which was regarded as the 100% oxygen level (250 µM oxygen). Control samples contained 2 µM Ero1-(WT) or 10 µM PDI in the presence of 10 mM GSH. Oxidation of reduced PDI was initiated by the injection of 2 µM Ero1- or Ero1-(C104A/C131A) and was monitored with an oxygen electrode. (F) Schematic and representative diagrams of the active (O x1 ) and inactive (O x2 ) forms of Ero1- and its constitutively active mutant Ero1-(C104A/C131A). Figure S2 . Validation of siRNA silencing and annotation of Cys94 with a double-labeling method. (A) siRNA-mediated silencing in HEK293T cells was achieved via transfection of predesigned siRNAs. The sequences and concentrations are summarized in the bottom table. As controls, two different siRNAs (L, low GC content; M, medium GC content) were used, depending on the GC content of each siRNA. At 72 h after transfection, cell lysates were analyzed by SDS-PAGE and immunoblotted against the target protein and GAPDH. Endogenous expression levels of PDI under each siRNA silencing condition were detected as controls and are shown in the bottom row in A. Numbers below indicate knockdown efficiency. (B) 13 C NMR spectra of constitutively active Ero1-, which was selectively labeled with 13 C at the carbonyl carbons of cysteine residues ([1- . The spectrum of the unlabeled protein has been subtracted. The asterisk indicates the peak originating from Cys94, which was significantly reduced after selective double labeling as a result of rapid transverse nuclear spin relaxation (Serve et al., 2010) . WB, Western blot; A.U., arbitrary unit. Figure S3 . PDI(AA) does not accelerate the Ero1- oxidation system. (A-C) Oxygen consumption was assayed in the presence of 10 mM GSH and 10 µM ERp46 (A), ERp57 (B), and P5 (C) either with or without 5 µM PDI(AA). Figure S4 . Method used to calculate the K eq values. The following procedure was used to calculate the K eq values from SDS-PAGE bands. To simplify the model, the redox protein containing one active domain is shown. (A) Free sulfhydryl groups on the cysteine residues were modified with mPEG2000-mal (molecular weight of 2,000) after incubation with different [GSH] 2 /[GSSG] ratios in a buffer containing GSSG and varying concentrations of GSH followed by SDS-PAGE and CBB staining. The active sites of the reduced form (vi, blue column) were modified with mPEG2000-mal. As a result, the reduced form migrated more slowly than the oxidized form. After CBB staining, the mean intensity of the horizontal pixels in each box was calculated along a line from the lower side of the fully oxidized form a to the upper side of the fully reduced form b using ImageJ (National Institutes of Health). (B) The x axis represents the longitudinal axis in A, and the y axis is the calculated mean pixel intensity. Total intensities were calculated using the integration shown in C. Table S1 . List of publications reporting Ero1--related assays and having a bearing on this study Jessop et al., 2009b; Schulman et al., 2010; Jessop et al., 2007 , 2009a Schulman et al., 2010 Jessop et al., 2009b Jessop et al., 2009b Schulman et al., 2010 Schulman et al., 2010 ERp18 In vitro binding assays (e.g., SPR assay and ITC measurements) 1 B and S1, C and D Wang et al., 2009; Inaba et al., 2010; Araki and Nagata, 2011a; Masui et al., 2011 Masui et al., 2011 Inaba et al., 2010 ITC, isothermal titration calorimetry. a Otsu et al. (2006) examined the redox states of Ero1- when PDI or ERp44 was overexpressed. However, at that time, the redox states of Ero1- were unknown to correlate with its activation. b Because ERp44 has a CRFS motif, it has no detectable redox activity. Hence, it was not listed under the oxygen consumption assay.
